Remdesivir therapy for severe pediatric COVID‐19 in Singapore: A single‐center retrospective observational cohort study
Abstract Background and Aims There is a paucity of information on remdesivir (RDV) use in severe pediatric coronavirus disease 2019 (COVID‐19). We aimed to explore the effectiveness of RDV as the cumulative proportion of pediatric COVID‐19 patients deescalated from Day 5 of high dependency or intens...
Main Authors: | Valerie Xue Fen Seah, Rina Yue Ling Ong, Kai Qian Kam, Koh Cheng Thoon, Natalie Woon Hui Tan, Jiahui Li, Karen Donceras Nadua, Chia Yin Chong, Chee Fu Yung |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Health Science Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/hsr2.1698 |
Similar Items
-
Remdesivir therapy for severe pediatric COVID-19 in Singapore: a single-center retrospective observational cohort study
by: Seah, Valerie Xue Fen, et al.
Published: (2024) -
Remdesivir – Current evidence & perspective in management of COVID-19 infection
by: Jyoti Bajpai, et al.
Published: (2021-01-01) -
The Effectiveness of the Use of Regdanvimab (CT-P59) in Addition to Remdesivir in Patients with Severe COVID-19: A Single Center Retrospective Study
by: Ganghee Chae, et al.
Published: (2022-03-01) -
Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study
by: Abigail Schulz, et al.
Published: (2024-02-01) -
Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report
by: Yudianto Budi Saroyo, et al.
Published: (2021-05-01)